ORGS
Orgenesis Inc
Halal Rating :
Last Price
$2.13
Last updated:
Market Cap
-
7D Change
0.71%
1 Year Change
138.18%
Company Overview
Industries
Exchange
Next Earnings Date
Orgenesis Inc. is a global biotech company focused on cell and gene therapy, including development, manufacturing, and processing of cell therapies. The company operates through its Cell & Gene Therapy Biotech Platform, which includes therapeutic development programs as well as its POCare technology platform designed to decentralize production of cell and gene therapy products.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $347000.0 | $8.74m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $246000.0 | $4.5m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $141000.0 | $9.21m | - | $141000.0 | 0.00% | 1.53% |
Company Impact
Help us evaluate Orgenesis Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.